Illumina stock heads into the open after a 6.9% jump
Published on 09/18/2026 at 05:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina stock closed at USD 244.78 on the Nasdaq on September 17, 2026, gaining 6.92% from the prior session’s level on a strong day for technology shares. Per Nasdaq data from MoneyDJ, the share price traded between an intraday low of USD 233.74 and a high of USD 246.66, with an average price of USD 242.16 and a reported volume of about 186,300 shares on the day.
September 17, 2026 in numbers
Illumina Inc. (ISIN US4523271090, Nasdaq: ILMN) saw its shares open at USD 233.95 on September 17, 2026 and then climb to a closing price of USD 244.78, marking a 6.92% advance for the session, according to closing figures summarized by MoneyDJ. The trading range between USD 233.74 and USD 246.66 placed the close toward the upper end of the day’s band and above the reported average trade price of USD 242.16 for the session. The roughly 186,300 shares that changed hands on the Nasdaq represented an active day compared with quieter periods earlier in the month, underscoring the renewed investor interest in the name.
While no single company-specific headline dominated the tape, Illumina’s move came against a favorable backdrop for growth and technology stocks. The Nasdaq Composite index rose 1.76% to close at 26,434.77 on September 17, 2026, as reported in a technology-led market wrap by Scanx.trade, meaning Illumina outperformed the broader tech-heavy benchmark on the day by more than 5 percentage points. Separate commentary on sector momentum noted that Illumina shares recently touched a 52-week high near USD 236 in the prior session, as highlighted by Finanzen.ch, so the latest close extends that breakout and pushes the stock further above its earlier high.
Today’s focus for Illumina
Today, September 18, 2026, Illumina heads into the US session without a scheduled earnings release or shareholder meeting explicitly flagged in the latest public calendars, and recent reporting does not indicate that the company is due to publish quarterly results within the next few days. However, the broader environment for growth and biotechnology remains supportive after the strong Nasdaq performance on September 17, 2026 described by Scanx.trade, which may keep attention on names that have recently set fresh 52-week highs. In that context, Illumina’s extended move beyond the USD 236 level previously identified as a 52-week high by Finanzen.ch positions the stock as one of the more momentum-driven biotech names to watch as trading resumes today.
